Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇦CA · Courses#1955K to 30K
- 🇳🇬NG · Courses#193500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.8K to 17K🎙 ~2x weekly·128 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
5.5K to 33K🇨🇦91%🇳🇬9% - Active Followers
Loyal subscribers who consistently listen
2.2K to 13K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Reassessing Tramadol Use in Chronic Pain
Jun 1, 2026
29m 30s
Episode 25: The Insider’s Guide to McKesson ideaShare 2026
May 27, 2026
23m 43s
Safe and Informed Use of Melatonin in Pediatric Patients
May 25, 2026
37m 10s
A Review of Acute Rescue Therapies in Clinical Practice
May 18, 2026
32m 02s
MOUD Prescribing Authority and Practice Implications
May 11, 2026
50m 45s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/1/26 |  Reassessing Tramadol Use in Chronic Pain | Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain mana... | 29m 30s | ||||||
| 5/27/26 | Episode 25: The Insider’s Guide to McKesson ideaShare 2026 | Join host Dr. Britney Woods, PharmD, Senior Manager on the McKesson Health Mart team, for a special Know Before You Go episode created to help independent pharmacy owners get real value from McKesson ideaShare 2026 - before they even arrive. Featuring Jaime Montuoro, PharmD, Director of Education and Practice Advancement with McKesson/Health Mart, Alanna Douglas, Senior Marketing Manager on the McKesson/Health Mart team, this conversation goes behind the scenes of how ideaShare is intentional... | 23m 43s | ||||||
| 5/25/26 |  Safe and Informed Use of Melatonin in Pediatric Patients | Melatonin—widely available over the counter and often perceived as “natural and safe”—has become increasingly used by caregivers to address sleep disturbances in children and adolescents, yet its proper role and safety profile in pediatrics remain nuanced and evolving. This course examines current evidence on indications such as insomnia and circadian rhythm sleep disorders, highlights concerns about unregulated supplement use and adverse effects, and reviews practical considerations for safe... | 37m 10s | ||||||
| 5/18/26 |  A Review of Acute Rescue Therapies in Clinical Practice | Acute rescue medications are critical in time-sensitive emergencies, and pharmacists play an essential role in ensuring patients and caregivers are prepared to use them correctly. This course discusses the roles of glucagon, naloxone, and epinephrine, including recent updates on novel formulations and device innovations that are reshaping emergency response in community settings. You will gain practical insights to strengthen counseling, improve readiness, and support optimal outcomes when se... | 32m 02s | ||||||
| 5/11/26 |  MOUD Prescribing Authority and Practice Implications | Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain ... | 50m 45s | ||||||
| 5/4/26 |  Practical Updates From the New Cholesterol Guidelines | Updated cholesterol guidelines introduce important changes in cardiovascular risk assessment and lipid management that directly impact pharmacist practice. This course reviews key updates from the new ACC/AHA dyslipidemia guideline, including risk assessment tools, LDL-C targets, and evolving roles for statin and nonstatin therapies. You will be better prepared to identify practice-relevant recommendations and support evidence-based lipid management in patient care. HOST Rachel Maynard, Pharm... | 40m 53s | ||||||
| 4/29/26 | Episode 24: Automation That Works: How Independent Pharmacies Decide, Implement, and Thrive | Join host Dr. Britney Woods, PharmD, Sr. Manager of Community Pharmacy at McKesson Health Mart, for a compelling conversation about the power of automation in independent pharmacies. This episode features special guests Faisal Adam, Pharmacist at Mark’s Pharmacy, and Alisha Nanji, Pharmacy Manager with McKesson Canada, who share their firsthand experiences on how thoughtfully implemented automation can help transform daily operations, ease the workload for pharmacy teams, and elevate patient ... | 49m 56s | ||||||
| 4/27/26 |  Help Patients Navigate Seasonal Allergies | Seasonal allergies affect millions of patients each year and are a common reason individuals seek guidance from pharmacists for symptom relief and product selection. This course reviews the pathophysiology, common symptoms, and current management strategies for seasonal allergies, with a focus on over-the-counter treatment options and patient counseling considerations. You will strengthen your ability to recommend evidence-based therapies, differentiate treatment options, and support patients... | 29m 52s | ||||||
| 4/20/26 |  Pharmacy’s Role in HPV Self‑Screening | Federal guidelines now recognize self‑collected HPV testing as an option for cervical cancer screening for average‑risk individuals, offering a more accessible and patient‑preferred alternative to clinician‑collected samples. This course explains current guideline updates supporting self‑collection, highlights screening intervals and follow‑up recommendations, and explores how pharmacists can support patients in choosing appropriate screening options and navigating coverage and reimbursement.... | 33m 33s | ||||||
| 4/13/26 |  Atopic Dermatitis Treatment and Guideline Updates | Treatment for atopic dermatitis has changed dramatically, with new therapies offering more targeted relief across the severity spectrum. This course highlights recent drug approvals, updated guideline recommendations, and the clinical implications of managing atopic dermatitis as a chronic inflammatory condition. You will learn how pharmacists can guide therapy decisions, enhance adherence, and improve patient outcomes in personalized atopic dermatitis care. HOST Rachel Maynard, PharmD... | 33m 32s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/6/26 |  Hypertension Updates Every Pharmacist Should Know | Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmac... | 47m 40s | ||||||
| 3/30/26 |  Alpha-Gal Syndrome and the Role of the Pharmacist | Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford to overlook. This course discusses the pathophysiology of the syndrome, common triggers, and emerging case trends—while highlighting how pharmacists can play a critical role in helping patients navigate safe OTC and prescription therapies by screening for allergenic excipients. You will gain practical knowledge to support patient education, ensure safe medicati... | 33m 13s | ||||||
| 3/25/26 | Episode 23: Community Roots to Clinical Impact: Inside a Pharmacy of the Year Winner | What does it look like to build a pharmacy that not only survives—but thrives? In this episode of Independent Insights, host Britney Woods talks with Dave Randolph, owner of Dave’s Pharmacy, and Mikayla Smith, pharmacy manager, about their journey as an independent pharmacy serving rural communities. Together, these Health Mart Pharmacy of the Year award winners discuss expanding clinical services, supporting staff through growth, and finding sustainable ways to meet patient needs when access... | 49m 24s | ||||||
| 3/23/26 |  How AI is Reshaping Patient Care | Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses of AI in pharmacy practice, including workflow automation, drug information access, and tools that support patient care and clinical decision-making. You will gain insight into practical considerations, limitations, and ethical responsibilities pharmacists must navigate as AI becomes more integrated into practice. HOST Rachel Maynard, Ph... | 35m 23s | ||||||
| 3/16/26 |  Second-Generation Antipsychotics as Adjunctive Therapy for Depression | Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have an inadequate or partial response to antidepressants. This course reviews the clinical rationale for their use, highlights newly approved options, and examines key safety, efficacy, and monitoring considerations. You will gain practical guidance to support patient selection, counseling, and shared decision-making when these agents are incor... | 34m 24s | ||||||
| 3/9/26 |  Recent Updates on GLP-1 Therapies | GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care. ... | 46m 20s | ||||||
| 3/2/26 |  Shared Clinical Decision-Making and the Pharmacist’s Role | Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and careg... | 43m 19s | ||||||
| 2/25/26 | Episode 22: Top 10 Reasons to Press Play | A familiar format, a subtle shift, and something worth sticking around for. This episode includes an introduction to the next chapter of Independent Insights. Host Suzanne Feeney, PharmD Sr. Director, Pharmacy Solutions McKesson / Health Mart Guests Britney Woods, PharmD Sr. Manager, Community Pharmacy McKesson / Health Mart The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its a... | 4m 54s | ||||||
| 2/23/26 |  Balancing the Benefits and Risks of Gabapentin | As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety concerns, and examines pharmacist-led opportunities to reduce risks through education and medication review. You will walk away with timely insights to help navigate the growing complexities and responsibilities associated with gabapentin use. HOST Rachel Ma... | 29m 53s | ||||||
| 2/16/26 |  Updates in HIV PEP Protocols and Guidelines | Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course summarizes key changes, including preferred regimens, testing/follow‑up modifications, and special‑population considerations, and explores how these updates influence clinical practice. You will gain the practical knowledge needed to inform prompt PEP ... | 41m 13s | ||||||
| 2/9/26 |  Updates in HIV PrEP Therapy Options | Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance — are changing the landscape of Pre-Exposure Prophylaxis (PrEP) therapy. This course reviews the latest developments, compares prevention strategies, and examines how these changes affect PrEP delivery, counseling, and monitoring. You will gain timely insights to better counsel patients, support adherence, and contribute to prevention strategies in your practice. HO... | 39m 40s | ||||||
| 2/2/26 |  The Role of Biosimilars in Managing Inflammatory Disease | With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions. HOST Rachel Maynard, PharmD GameChange... | 41m 25s | ||||||
| 1/28/26 | Episode 21: Inside NIAB – Shaping the Future of Independent Pharmacy | Join us for a special live episode of Independent Insights as we sit down with members of the National Independent Advisory Board (NIAB), at McKesson ideaShare, to explore their vision for the future of pharmacy. Hear firsthand what they’ve learned from McKesson ideaShare (MiS), what excites them most about the road ahead, and how they’re working to elevate the voice of independent pharmacy across the country. Host Suzanne Feeney, PharmD Sr. Director, Pharmacy Solutions McKesson / Health Mart... | 20m 00s | ||||||
| 1/26/26 |  FDA Removes Boxed Warnings on Menopausal Hormone Therapy | Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the therapy's risk-benefit profile for all patients. This course discusses the FDA's recent removal of boxed warnings for select hormone therapy (HT) products, the rationale for this change, and how evolving guidance may impact patient care. You will explore strategies to support evidence-based counseling and individualized decision-making for patients considering HT. ... | 41m 35s | ||||||
| 1/19/26 |  Key Updates on the Return of Ranitidine | Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated version, raising important questions for pharmacists and patients alike. This course outlines the FDA’s recent approval, reviews the reformulated product's changes (including manufacturing and labeling), and examines practical considerations for dispensing, counseling, and patient safety. You will gain clarity on when ranitidine may be appropriate for use (again) and how to... | 31m 32s | ||||||
Showing 25 of 137
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.